Effects of Social Networking on Chronic Disease Management in Arthritis
Phase 2 & Phase 3, Effects of Social Networking on Chronic Disease Management in Arthritis
3 other identifiers
interventional
210
1 country
1
Brief Summary
Objectives: The overall goal of this study is to use the principles of chronic disease management to develop and test an online social networking intervention using the FB platform in a randomized controlled trial. Our specific objectives are as follows: Aim 1: To develop and establish an independent closed community in FB for patients with rheumatoid arthritis, providing an educational platform for disease self-management and the potential for engaging in social networking with peers (Phase 2). Objective 1. To beta test the features and navigation buttons and panels in the newly developed website and FB group. Objective 2. To evaluate the contents, ease of use and satisfaction with the newly developed website and FB group by patient advocates (consultants to the study) who participate as members of the Facebook community. Aim 2: To evaluate the efficacy of the FB community intervention combined with an educational website to improve patients' self-management (including knowledge, which is the primary outcome), decision making and patient-reported outcomes compared with the educational website alone (Phase 3). We hypothesize that participation in an online closed community offering evidence-based information combined with peer interaction and support will improve patients' knowledge.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_2
Started Apr 2016
Longer than P75 for phase_2
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 18, 2016
CompletedFirst Posted
Study publicly available on registry
March 23, 2016
CompletedStudy Start
First participant enrolled
April 7, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 7, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
June 7, 2023
CompletedJune 18, 2023
June 1, 2023
7.2 years
March 18, 2016
June 14, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Participant Knowledge of Rheumatoid Arthritis assessed with the Patient Knowledge Questionnaire (PKQ-RA)
The Patient Knowledge Questionnaire (PKQ-RA) will measure this outcome.
6 months
Secondary Outcomes (1)
Control in Health Care Decisions assessed with the Control Preferences Scale (CPS-RA)
6 months
Study Arms (3)
Facebook + Website Group
EXPERIMENTALParticipants complete a self response electronic questionnaire at baseline. Participant shown how to access the Educational Website and the Facebook page on the internet about rheumatoid arthritis. Patients assessed at three and six months after baseline via email self response electronic questionnaires.
Educational Website Group
EXPERIMENTALParticipants complete a self response electronic questionnaire at baseline. Participant shown how to access the Educational Website on the internet about rheumatoid arthritis. Content includes the following: (i) a learning center; (ii) relevant links to other evidence-based web pages; (iii) news released by major rheumatology and dermatology organizations/societies; and (iv) chronic disease management strategies. Participants assessed at three and six months after baseline via email self response electronic questionnaires.
Pilot Testing Group
EXPERIMENTALParticipants access the Educational Website and Facebook page about rheumatoid arthritis for a period of one week. After 1 week, research staff calls participant to obtain feedback about the websites. The interview will last approximately 30 minutes.
Interventions
Participants complete a self response electronic questionnaire at baseline, and at three and six months.
Participant accesses Facebook page regarding rheumatoid arthritis.
Participant accesses Educational Website on the internet about rheumatoid arthritis.
Research staff calls participant to obtain feedback about the websites. The interview will last approximately 30 minutes.
Eligibility Criteria
You may qualify if:
- Age 18 years or older (usability test and RCT)
- Staff of the Department of General Internal Medicine (usability test)
- Diagnosis of rheumatoid arthritis by a rheumatologist (RCT)
- Ongoing or prior treatment with traditional disease-modifying anti-rheumatic drugs or biologic agents (RCT)
- Adequate cognitive status as determined by a research coordinator at recruitment. To assess the participant's capacity to take part in the interview, the interviewer will note and comment on the participant's spontaneous speech and capacity to write date at the time of consent. Participants should be oriented to person, place, date, time, and events (RCT)
- Living in the community (not institutionalized, etc. ) (RCT)
- Able to communicate in English (RCT)
- Use internet on average at-least once a week (RCT);
- Disease duration 10 years or less (RCT)
- Familiarity with and participation in social media (e.g. Facebook) (usability test and RCT)
You may not qualify if:
- Participants not willing to complete interviews or survey instruments (usability test and RCT)
- Hospitalized (RCT)
- Patients who do not verbally, written, or electronically consent to participate (usability test and RCT)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- M.D. Anderson Cancer Centerlead
- Rheumatology Research Foundationcollaborator
Study Sites (1)
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
Related Publications (1)
Lopez-Olivo MA, Foreman JT, Leung C, Lin HY, Westrich-Robertson T, Hofstetter C, des Bordes JKA, Lyddiatt A, Leong A, Willcockson IU, Peterson SK, Suarez-Almazor ME. A randomized controlled trial evaluating the effects of social networking on chronic disease management in rheumatoid arthritis. Semin Arthritis Rheum. 2022 Oct;56:152072. doi: 10.1016/j.semarthrit.2022.152072. Epub 2022 Jul 16.
PMID: 35872394DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Angeles M. Lopez-Olivo, MD, PHD, MS
M.D. Anderson Cancer Center
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 18, 2016
First Posted
March 23, 2016
Study Start
April 7, 2016
Primary Completion
June 7, 2023
Study Completion
June 7, 2023
Last Updated
June 18, 2023
Record last verified: 2023-06